Arkolith/Insider Trading/VIRI/Form 4/A

Duncan Gregory Scott

Chief Executive Officer, DirectorVirios Therapeutics, Inc. (VIRI) · full profile →Form 4/A · filed Apr 6, 2021
Net Buying
Open-Market Buys
$97K
Open-Market Sells
$0
Net Open-Market Flow
$97K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 5, 2021Buy(P)16K$6.17$97K20K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-21-047253) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML